Software Healthcare Sector

Vera Therapeutics

Market Cap: US$2.8b

A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases.

Beam Therapeutics

Market Cap: US$2.7b

A biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.

Establishment Labs Holdings

Market Cap: US$2.7b

A medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States.

Trevi Therapeutics

Market Cap: US$2.7b

A clinical-stage biopharmaceutical company, develops and commercializes investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough.

EBOS Group

Market Cap: NZ$4.6b

Engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand.

AtaiBeckley

Market Cap: US$2.7b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

Kodiak Sciences

Market Cap: US$2.7b

A clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.

Extendicare

Market Cap: CA$3.7b

Through its subsidiaries, provides care and services for seniors in Canada.

SELLAS Life Sciences Group

Market Cap: US$2.6b

A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.

Tarsus Pharmaceuticals

Market Cap: US$2.6b

A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.

Guardian Pharmacy Services

Market Cap: US$2.6b

A pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States.

TransMedics Group

Market Cap: US$2.6b

A commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.

Immunome

Market Cap: US$2.5b

A biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States.

Progyny

Market Cap: US$2.5b

A benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States.

Regencell Bioscience Holdings

Market Cap: US$2.5b

Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.

Curaleaf Holdings

Market Cap: CA$3.5b

Engages in the retail and wholesale of cannabis products in the United States and internationally.

Pharvaris

Market Cap: US$2.4b

A late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.

Clover Health Investments

Market Cap: US$2.4b

Provides medicare advantage plans in the United States.

Kailera Therapeutics

Market Cap: US$2.4b

Operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions.

Nurix Therapeutics

Market Cap: US$2.4b

A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

Mineralys Therapeutics

Market Cap: US$2.4b

A biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.

Vericel

Market Cap: US$2.4b

A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.

Prestige Consumer Healthcare

Market Cap: US$2.4b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

BioCryst Pharmaceuticals

Market Cap: US$2.4b

A biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases.

Agios Pharmaceuticals

Market Cap: US$2.4b

A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.

Biohaven

Market Cap: US$2.3b

A biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide.

LeMaitre Vascular

Market Cap: US$2.3b

Develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.

Nektar Therapeutics

Market Cap: US$2.3b

A biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally.

Hemab Therapeutics Holdings

Market Cap: US$2.3b

Operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denmark.

Zai Lab

Market Cap: US$2.3b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Palvella Therapeutics

Market Cap: US$2.3b

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases.

Neogen

Market Cap: US$2.2b

Develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally.

Iovance Biotherapeutics

Market Cap: US$2.2b

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally.

Sionna Therapeutics

Market Cap: US$2.2b

A clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).

agilon health

Market Cap: US$2.2b

Provides healthcare services for seniors through primary care physicians in the communities of the United States.

HeartFlow

Market Cap: US$2.1b

A medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide.